# OnCo record mrd-negativity-myeloma (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/mrd-negativity-myeloma/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "mrd-negativity-myeloma" ;
  schema:name "MRD negativity (myeloma, 10⁻⁵ / 10⁻⁶)"@en ;
  schema:description "MRD negativity means no detectable myeloma cell among 100,000 or a million marrow cells. It is the best predictor of long survival and, since 2024, an accepted endpoint for accelerated approval."@en ;
  schema:url <https://onco.cc/terms/mrd-negativity-myeloma/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Minimal_residual_disease> ;
  schema:citation <https://doi.org/10.1016/S1470-2045(16)30206-6> ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:terms <https://onco.cc/terms/mrd/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-kumar-lancet-oncol/> .